Alignment Healthcare (NASDAQ:ALHC) Shares Gap Down After Insider Selling

Alignment Healthcare, Inc. (NASDAQ:ALHC) shares gapped down before the market opened on Thursday after an insider sold shares in the company. The stock had previously closed at $16.45, but opened at $15.75. Alignment Healthcare shares last traded at $15.37, with a volume of 1,686,016 shares changing hands.

Specifically, CEO John E. Kao sold 180,000 shares of the company’s stock in a transaction dated Wednesday, September 10th. The shares were sold at an average price of $16.42, for a total value of $2,955,600.00. Following the sale, the chief executive officer owned 1,193,100 shares of the company’s stock, valued at $19,590,702. This represents a 13.11% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO John E. Kao sold 355,018 shares of the company’s stock in a transaction dated Wednesday, September 10th. The shares were sold at an average price of $16.41, for a total transaction of $5,825,845.38. Following the completion of the sale, the chief executive officer directly owned 4,533,568 shares in the company, valued at $74,395,850.88. This trade represents a 7.26% decrease in their position. The disclosure for this sale can be found here. In other Alignment Healthcare news, Director Joseph S. Konowiecki sold 25,000 shares of the company’s stock in a transaction dated Tuesday, September 9th. The shares were sold at an average price of $17.00, for a total value of $425,000.00. Following the sale, the director owned 1,127,049 shares of the company’s stock, valued at $19,159,833. This represents a 2.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Wall Street Analysts Forecast Growth

ALHC has been the subject of a number of analyst reports. Barclays raised shares of Alignment Healthcare from an “underweight” rating to an “equal weight” rating and boosted their price objective for the company from $9.00 to $13.00 in a research report on Thursday, July 31st. Wall Street Zen lowered shares of Alignment Healthcare from a “buy” rating to a “hold” rating in a research report on Sunday, August 10th. Stephens raised shares of Alignment Healthcare to a “strong-buy” rating in a research report on Monday, June 2nd. KeyCorp raised shares of Alignment Healthcare from a “sector weight” rating to an “overweight” rating and set a $21.00 price objective for the company in a research report on Monday, August 25th. Finally, Zacks Research raised shares of Alignment Healthcare to a “hold” rating in a research report on Friday, August 8th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Alignment Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $18.83.

Alignment Healthcare Stock Down 0.6%

The company has a debt-to-equity ratio of 2.29, a current ratio of 1.66 and a quick ratio of 1.66. The firm’s 50-day moving average is $14.37 and its 200 day moving average is $15.49. The stock has a market cap of $3.24 billion, a price-to-earnings ratio of -58.39 and a beta of 1.17.

Alignment Healthcare (NASDAQ:ALHC) last issued its quarterly earnings results on Wednesday, July 30th. The company reported $0.07 EPS for the quarter, topping the consensus estimate of ($0.07) by $0.14. Alignment Healthcare had a negative net margin of 1.53% and a negative return on equity of 43.68%. The firm had revenue of $1.02 billion during the quarter, compared to analyst estimates of $960.25 million. During the same quarter in the prior year, the business posted ($0.13) earnings per share. Alignment Healthcare’s revenue for the quarter was up 49.0% compared to the same quarter last year. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Sell-side analysts anticipate that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Alignment Healthcare

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. increased its position in Alignment Healthcare by 13.2% during the first quarter. Vanguard Group Inc. now owns 11,113,896 shares of the company’s stock worth $206,941,000 after purchasing an additional 1,295,825 shares during the last quarter. T. Rowe Price Investment Management Inc. increased its position in shares of Alignment Healthcare by 5.0% in the first quarter. T. Rowe Price Investment Management Inc. now owns 9,078,113 shares of the company’s stock worth $169,035,000 after acquiring an additional 429,071 shares in the last quarter. Wellington Management Group LLP increased its position in shares of Alignment Healthcare by 0.9% in the first quarter. Wellington Management Group LLP now owns 7,509,057 shares of the company’s stock worth $139,819,000 after acquiring an additional 70,557 shares in the last quarter. Hood River Capital Management LLC increased its position in shares of Alignment Healthcare by 6.0% in the second quarter. Hood River Capital Management LLC now owns 5,517,336 shares of the company’s stock worth $77,243,000 after acquiring an additional 311,424 shares in the last quarter. Finally, 8 Knots Management LLC increased its position in shares of Alignment Healthcare by 6.4% in the second quarter. 8 Knots Management LLC now owns 5,015,881 shares of the company’s stock worth $70,222,000 after acquiring an additional 300,409 shares in the last quarter. Institutional investors and hedge funds own 86.19% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.